NCT02733588View on ClinicalTrials.gov

Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 5, 2017

Study Completion Date

June 1, 2017

Conditions
HypoglycemiaComplications of Bariatric Procedures
Interventions
DRUG

G-Pump™ (glucagon infusion)

0.15 or 0.3 mg G-Pump™ (glucagon infusion) administered from OmniPod® pump

Trial Locations (1)

02215

Joslin Diabetes Center, Boston

Sponsors
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Xeris Pharmaceuticals

INDUSTRY